Clearline Capital’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-436,437
| Closed | -$999K | – | 135 |
|
2024
Q3 | $999K | Sell |
436,437
-800
| -0.2% | -$1.83K | 0.04% | 115 |
|
2024
Q2 | $1.28M | Hold |
437,237
| – | – | 0.04% | 112 |
|
2024
Q1 | $1.59M | Sell |
437,237
-57,269
| -12% | -$208K | 0.08% | 92 |
|
2023
Q4 | $747K | Hold |
494,506
| – | – | 0.05% | 84 |
|
2023
Q3 | $663K | Hold |
494,506
| – | – | 0.06% | 109 |
|
2023
Q2 | $890K | Hold |
494,506
| – | – | 0.05% | 89 |
|
2023
Q1 | $821K | Hold |
494,506
| – | – | 0.12% | 79 |
|
2022
Q4 | $949K | Hold |
494,506
| – | – | 0.17% | 87 |
|
2022
Q3 | $1.11M | Hold |
494,506
| – | – | 0.13% | 96 |
|
2022
Q2 | $1.6M | Hold |
494,506
| – | – | 0.21% | 76 |
|
2022
Q1 | $2.6M | Sell |
494,506
-33,271
| -6% | -$175K | 0.3% | 73 |
|
2021
Q4 | $4.27M | Buy |
527,777
+141,836
| +37% | +$1.15M | 0.47% | 52 |
|
2021
Q3 | $3.84M | Buy |
385,941
+165,137
| +75% | +$1.64M | 0.36% | 60 |
|
2021
Q2 | $2.06M | Buy |
220,804
+196,813
| +820% | +$1.83M | 0.31% | 69 |
|
2021
Q1 | $251K | Buy |
+23,991
| New | +$251K | 0.03% | 106 |
|